XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Reporting cash rewards on your taxes can be confusing. Find out what you need to know to ensure you report correctly and avoid issues.
21,129 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
MBA researchers project 2025 real GDP around 2.5% with consumer spending staying resilient, while FHA delinquencies r...
A landmark ruling reshapes trade policy and could alter stock market dynamics. This guide breaks down what happened, ...
A Supreme Court ruling blocks Trump’s emergency tariffs, leaving executives silent as refunds, labor concerns, and ma...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
Defensive staples shares are delivering steady gains even as the broader market wobbles. Retirees are taking note as ...
The stock market live february narrative took a turn as Nvidia’s earnings digest kept major averages flat, with SPY h...
U.S. stocks pulled back on February 27, 2026, with the S&P 500 slipping roughly 0.8% as technology led declines and s...
Markets brace for spillovers as tensions with Iran rise. This report examines how 'military action iran broader' coul...
Palantir’s latest quarter reported strong numbers and rising defense-related AI demand, boosting the stock and signal...
Markets swing as geopolitical tensions flare between the U.S. and Iran. This analysis traces the past CIA plan and ex...
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...